Pharma Friday – July 10, 2026

Published on July 10, 2026

Vertex to Acquire Crinetics Pharmaceuticals On July 6, Vertex Pharmaceuticals, Inc., and Crinetics Pharmaceuticals, Inc., a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of […]

The post Pharma Friday – July 10, 2026 appeared first on Endocrine News.

Continue reading on website
Other news

Game Changer: 2026 Bardin Award Winner Rok Herman, MD

July 9, 2026
Rok Herman, MD, (above, with Patricia Morris, PhD (center), and Mojca Jensterle, MD, PhD, one of Herman’s mentors, at the Excellence in Endocrinology Dinner that took place during ENDO 2026 in Chicago, Ill.) speaks to Endocrine News after taking home the 2026 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO 2026 abstract […]The post Game Changer: 2026 Bardin Award Winner Ro

Happy Accidents

July 14, 2026
After having her study, “Unanticipated remission of primary hyperparathyroidism following cinacalcet,” published in JCEM Case Reports in March, early-career member Sara Ramadan, MD, discusses what her research could mean for the future treatment of PHPT, as well as why joining the Endocrine Society has impacted her career and her research. When Sara Ramadan, MD, began […]The post Happy Accidents a